Concepedia

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

Christopher J. Schmidt, Gina M. Fadayel, Christine K. Sullivan, Vicki L. Taylor

European Journal of Pharmacology · 1992 · 162 citations · 42 references

DOI

Concepts

References

42

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

Herbert Y. Meltzer, Shin Matsubara, J C Lee · Journal of Pharmacology and Experimental Therapeutics · 1989 · 1.4K citations

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity

Elizabeth O’Hearn, Giuseppe Battaglia, EB De Souza et al. · Journal of Neuroscience · 1988 · 546 citations · Full text

Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

C J Schmidt · Journal of Pharmacology and Experimental Therapeutics · 1987 · 530 citations

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.

Giuseppe Battaglia, S.Y. Yeh, Elizabeth O’Hearn et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 459 citations

Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

Deborah Commins, Georgetta Vosmer, Robert M. Virus et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 454 citations